Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Takeda Pharmaceutical Company

Takeda Pharmaceutical Company
PUBLIC STATUS
45K-50K EMPLOYEES
4502 STOCK SYMBOL
48 INVESTMENTS
$40.23 SHARE PRICE (As of Friday Closing)
Description

Takeda Pharmaceutical Co Ltd ("Takeda") is Japan's largest pharmaceutical company, with revenue of JPY 2.1 trillion in 2018. In January 2019, it closed its acquisition of Shire Plc ("Shire"), a diversified, Ireland-based specialty drug firm with $15 billion revenue in 2017, mostly derived from the U.S.. In future, management intends to focus future R&D and sales efforts on five areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which comprise approximately 75% of revenue. Its geographic footprint will increase in the U.S. and diversify away from Japan, with pro-forma distribution expected to be about 48% U.S, 20% Japan, and 32% in the Rest of the World, or RoW.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
TKS
Primary Office
  • 1-1, Nihonbashi-Honcho 2-Chome
  • Chuo-Ku
  • Tokyo, 103-8668
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Takeda Pharmaceutical Company’s full profile, request a free trial.

Takeda Pharmaceutical Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$32.16 - $43.42 $63.4B $40.09 -$0.24 4.4M 1.58B

Takeda Pharmaceutical Company Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 100,605,596 69,625,613 44,164,599 39,218,103
Revenue 26,142,026 18,915,530 15,971,882 15,985,469
EBITDA 5,009,154 3,687,828 3,663,284 2,956,237
Net Income 142,143 984,242 1,685,890 1,060,806
Total Assets 119,308,746 125,111,698 38,641,817 38,877,726
Total Debt 46,542,962 51,866,677 9,275,079 10,239,896
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Takeda Pharmaceutical Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Takeda Pharmaceutical Company‘s full profile, request access.

Request full access to PitchBook

Takeda Pharmaceutical Company Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hikma Pharmaceuticals Corporation London, United Kingdom 0000 00000 000000000 00000
000 00000000000000 Corporation Mumbai, India 00000 00000000000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
00000000 000000 Corporate Backed or Acquired Tokyo, Japan 00000 000000000000
000000 Corporation New York, NY 00000 000000 - 000
To view this company’s complete list of competitors, request access »

Takeda Pharmaceutical Company Investments & Acquisitions (48)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 19-Dec-2019 000000000 00000 Drug Discovery 00000000000 000000 00.0
0000 0000000000000 22-Oct-2019 000000000 00000 00 Buildings and Property
00000000 000000000 16-Oct-2019 00000 00000 00 00.000 Biotechnology
0000000 0000000000 15-May-2019 00000 0000000 Biotechnology 00000000 000000 00
Shire 08-Jan-2019 Merger/Acquisition 000.00 Pharmaceuticals 0000000000 00000
To view this company’s complete investment and acquisition history, request access »

Takeda Pharmaceutical Company Exits (8)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 07-Dec-2017 000000000 00000000 00000 Completed
  • 000000 00000000000
000000000 00000000 02-Aug-2017 0000 0000 Completed
  • 4 buyers
000 000000 0000000 15-Feb-2017 00000 0000000 Completed
  • 2 buyers
0000000 0000000000 14-Jun-2016 00000 00000 00 000.00 Completed
  • 7 buyers
Seattle Genetics 17-Jan-2014 PIPE 000 Completed
To view this company’s complete exits history, request access »

Takeda Pharmaceutical Company Subsidiaries (8)

Company Name Industry Location Founded
Crescendo Biologics Therapeutic Devices Cambridge, United Kingdom 2007
000000 00000000 Corporate Venture Capital Palo Alto, CA 0000
0000000 Biotechnology Leuven, Belgium 0000
000000 00000000 Medical Supplies Cambridge, MA 0000
000000 (0000000) Acquirer Konstanz, Germany 0000
To view this company’s complete subsidiary history, request access »

Takeda Pharmaceutical Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Takeda Pharmaceutical Company‘s full profile, request access.

Request full access to PitchBook

Takeda Pharmaceutical Company Executive Team (35)

Name Title Board
Seat
Contact
Info
Christophe Weber Chief Executive Officer & Board Member
Andrew Plump Ph.D Board Member & President
Giles Platford President
Rajeev Venkayya MD President
Ramona Sequeira President

11 Former Executives

You’re viewing 5 of 35 executives. Get the full list »

Takeda Pharmaceutical Company Board Members (15)

Name Representing Role Since Contact
Info
000000 00000 00.0 Takeda Pharmaceutical Company Board Member & President 000 0000
0000000000 00000 Takeda Pharmaceutical Company Chief Executive Officer & Board Member 000 0000
00000 00000000 Takeda Pharmaceutical Company Chief Financial Officer & Board Member 000 0000
00000 0000000 Self Board Member 000 0000
00000 0000 Takeda Pharmaceutical Company Outside Director 000 0000

2 Former Board Members

You’re viewing 5 of 15 board members. Get the full list »